These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6248965)

  • 21. Detection and quantitation of fibronectin in synovial fluid from patients with rheumatic disease.
    Carsons S; Mosesson MW; Diamond HS
    Arthritis Rheum; 1981 Oct; 24(10):1261-7. PubMed ID: 6975631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fibrin-fibrinogen degradation products in connective tissue diseases].
    Shchepotin BM; Ena IaM; Bodaretskiĭ GM
    Revmatologiia (Mosk); 1989; (2):64-8. PubMed ID: 2678401
    [No Abstract]   [Full Text] [Related]  

  • 23. [An immunonephelometric micromethod of determining the levels of fibrin-fibrinogen degradation products].
    Ivanov EP; Tsvirko DG
    Lab Delo; 1989; (10):12-5. PubMed ID: 2481061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoenzyme histochemical localization of fibrin degradation products in tissues.
    Emeis JJ; Lindeman J; Nieuwenhuizen W
    Am J Pathol; 1981 Jun; 103(3):337-44. PubMed ID: 7015871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elastase- and plasmin-mediated fibrinolysis in rheumatoid arthritis.
    Carmassi F; De Negri F; Morale M; Puccetti R; Chung SI
    Int J Tissue React; 1994; 16(2):89-93. PubMed ID: 7960505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Relation between fibrin/fibrinogen degradation products in malignant fluids and the fibrinolytic activity of the peritoneum].
    Takahashi M; Yoshida K; Kano K; Machida T; Nakamura Y; Miura Y; Miura N; Kanno S
    Gan No Rinsho; 1986 Dec; 32(15):1945-9. PubMed ID: 3806965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Quantitative assay of fibrinogen and fibrin grafts. Simple radial immunodiffusion and electroimmunoassay (author's transl)].
    Blatný J; Rozprínová L; Fiserová E; Frágner J
    Cas Lek Cesk; 1976 Jul; 115(28):861-4. PubMed ID: 821614
    [No Abstract]   [Full Text] [Related]  

  • 28. [Standarization of the staphylococcal clumping test (SCT) for the detection of fibrinogen/fibrin degradation products (FDP) in serum (author's transl)].
    Contreras P; Salazar R
    Rev Med Chil; 1975 Aug; 103(8):551-4. PubMed ID: 1197971
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies on the blood coagulation factor XIII in patients with increased levels of FDP D-dimer].
    Okumura N; Matsuzawa A; Terasawa F; Kameko M; Sasaki Y; Nakagoshi R; Ishikawa S; Hashikura Y; Matsunami H; Kawasaki S
    Rinsho Byori; 1995 Mar; 43(3):269-74. PubMed ID: 7745833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Quantification of the fibrinogen degradation products FDP-D and FDP-E in blood, using immunoenzyme analysis].
    León VJ; León E; López Borrasca A
    Sangre (Barc); 1986; 31(1):23-30. PubMed ID: 3085242
    [No Abstract]   [Full Text] [Related]  

  • 31. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of plasma fibrinogen and fibrin degradation products (FDP) in 100 normal persons and 32 cases of acute cerebrovascular disease (author's transl)].
    Wang GX
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Feb; 15(1):8-10. PubMed ID: 7094732
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of anesthesia and surgery on serum and urinary fibrinogen/fibrin degradation products (FDP) levels in man (author's transl)].
    Shinozaki Y; Takiguchi M; Oyama T
    Masui; 1978 Mar; 27(3):253-9. PubMed ID: 650865
    [No Abstract]   [Full Text] [Related]  

  • 34. Reactivity of soluble fibrin assays with plasmic degradation products of fibrin and in patients receiving fibrinolytic therapy.
    McCarron BI; Marder VJ; Francis CW
    Thromb Haemost; 1999 Dec; 82(6):1722-9. PubMed ID: 10613661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Information value of synovial fluid study in rheumatic diseases].
    Paskaleva-Peĭcheva V
    Vutr Boles; 1983; 22(4):6-10. PubMed ID: 6232760
    [No Abstract]   [Full Text] [Related]  

  • 36. Studies on the degradation of fibrinogen by proteolytic enzymes from the larvae of Lanomia achelous (Cramer).
    Arocha-Piñango CL; Perales J; Carvajal Z
    Thromb Haemost; 1981 Jun; 45(3):233-6. PubMed ID: 6456570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naturally occurring anti-inflammatory factors in the synovial fluids of patients with rheumatic disease and their possible mode of action.
    Capstick RB; Lewis DA; Cosh JA
    Ann Rheum Dis; 1975 Jun; 34(3):213-8. PubMed ID: 50763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum and urinary fibrin/fibrinogen degradation products (FDP) in patients with urologic malignancies (author's transl)].
    Ohtaki M
    Nihon Hinyokika Gakkai Zasshi; 1977 Dec; 68(12):1172-83. PubMed ID: 609173
    [No Abstract]   [Full Text] [Related]  

  • 39. [The usefullness of the fibrinogen degradation products (FDP) determination in the serum and urine in diagnostics and evaluation of effectiveness of therapy of nephropathy (author's transl)].
    Kwiecien-Głowacka E
    Przegl Lek; 1981; 38(3):335-40. PubMed ID: 7244292
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cyclic nucleotides and enzymes of the synovial fluid in various rheumatic diseases].
    Buneaux JJ; Djiane F; Gounelle JC; Galmiche P
    Rev Rhum Mal Osteoartic; 1980; 47(7-9):461-4. PubMed ID: 6968447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.